Revvity
Ning Lai's work experience includes serving as a Sales Director at Revvity since May 2023. Prior to that, Lai worked as a Sales Director in the Life Sciences Imaging division at PerkinElmer, Inc. starting in June 2022. Lai also held various roles at Nexcelom Bioscience, including Director of Business Development for North America East from January 2019 to June 2022, Regional Business Development Manager from September 2014 to December 2018, Territory Sales Manager from January 2012 to August 2014, and Field Application Scientist from July 2010 to December 2011.
Ning Lai completed a Ph.D. in Biotechnology Engineering from Tufts University between 2005 and 2010. Prior to that, they earned a bachelor's degree in Pharmaceutical Engineering from Beijing University of Chemical Technology, from 2001 to 2005.
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com